MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. (2023). Mediterranean Journal of Hematology and Infectious Diseases, 15(1), e2023047. https://doi.org/10.4084/MJHID.2023.047